Assessing Medical Menstrual Regulation in the United States

Menstrual Regulation Clinical Trial

Official title:
Assessing Acceptability and Use of Medical Menstrual Regulation in the United States

Status Recruiting

Clinical Trial Summary

This study will assess the acceptability and use of medical menstrual regulation among women in the United States.

Clinical Trial Description

Medical menstrual regulation (MMR) entails the use of uterine evacuation medications by women with late menses without confirming pregnancy status. Provision of MMR in the United States could expand reproductive choice and service options for women. This study will collect data on the acceptability, efficacy, safety and feasibility of MMR among women with missed menses of 1-21 days ;

Study Design

Related Conditions & MeSH terms

Menstrual Regulation

Clinical Trial Details

NCT number	NCT03972358
Study type	Interventional
Source	Gynuity Health Projects
Contact	Wendy R Sheldon, PhD
Phone	212-448-1230
Email	wsheldon@gynuity.org
Status	Recruiting
Phase	Phase 2
Start date	February 12, 2020
Completion date	December 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04940013` - Missed Period Pill Study	Phase 4
Completed	`NCT01954069` - Exploring the Role of At-home Semi-quantitative Pregnancy Tests for Follow-up to Menstrual Regulation Service	N/A
Completed	`NCT01798017` - Introducing Mifepristone-Misoprostol for Menstrual Regulation in Public Sector Facilities in Bangladesh	Phase 4